Andrew V. Fowler
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Fluoride geochemistry in groundwater at regulated industrial sites.
Journal: Water environment research : a research publication of the Water Environment Federation
Published: April 12, 2024
Clinic vs Home Spirometry for Monitoring Lung Function in Patients With Asthma.
Journal: Chest
Published: February 17, 2023
Study to Explore the Association of the Renin-Angiotensin System and Right Ventricular Function in Mechanically Ventilated Patients.
Journal: Journal of clinical medicine
Published: May 11, 2022
Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes.
Journal: NPJ primary care respiratory medicine
Published: December 21, 2021
Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study.
Journal: Current medical research and opinion
Published: June 24, 2021
Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study.
Journal: Journal of asthma and allergy
Published: February 09, 2021
Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN).
Journal: Clinical pharmacokinetics
Published: January 16, 2021
Measuring respiratory symptoms in moderate/severe asthma: evaluation of a respiratory symptom tool, the E-RS®: COPD in asthma populations.
Journal: Journal of patient-reported outcomes
Published: November 09, 2020
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
Journal: The Lancet. Respiratory medicine
Published: August 04, 2020
A nebulised antitumour necrosis factor receptor-1 domain antibody in patients at risk of postoperative lung injury: A randomised, placebo-controlled pilot study.
Journal: European journal of anaesthesiology
Published: May 30, 2020
FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods.
Journal: Pulmonary pharmacology & therapeutics
Published: December 12, 2019
Last Updated: 09/26/2026